Quest Diagnostics: Q2 Beat and Forecast Upgrade Boost the Stock
Reading Time: 2 minutes
News Factor: Better-than-expected Q2 results in revenue and profit, along with a significant upward revision of the full-year forecast for 2026, are driving trading volume massively. Future Perspective: As a US market leader in diagnostics, the company benefits from partnerships with Corewell Health and strong demand in clinical channels. Accumulation: Institutional investors are responding to the strong organic volume growth, while analysts are setting price targets of up to $245. As a global market leader and essential part of the US...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
